Figure 5.

Secondary endpoint (a) Improvement rate of edema (b) Improvement rate of redness (c) Improvement rate of hemorrhage (d) Improvement rate of gastrointestinal symptoms.

Secondary endpoint (a) Improvement rate of edema (b) Improvement rate of redness (c) Improvement rate of hemorrhage (d) Improvement rate of gastrointestinal symptoms.